Hapten resistant dextran induced ARDS reaction following intracoronary stent deployment

Catheterization and Cardiovascular Diagnosis

Volumn 38, Issue 1, 1996, Pages 56-61

  Gossman, David E ^a   Schneider, Franklin ^b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b NONE

Author keywords

ARDS; dextran; Intracoronary stents

Indexed keywords

ACETYLSALICYLIC ACID; DEXTRAN; DILTIAZEM; DIPHENHYDRAMINE; DIPYRIDAMOLE; HAPTEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; STEROID; WARFARIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD OXYGEN TENSION; CASE REPORT; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART CATHETERIZATION; HEMATOCRIT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OXYGEN SATURATION; STENT;

ANTICOAGULANTS; CORONARY VESSELS; DEXTRANS; DRUG RESISTANCE; FEMALE; HAPTENS; HUMANS; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; STENTS;

EID: 0029913328     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199605)38:1<56::AID-CCD12>3.0.CO;2-Q     Document Type: Article

References (39)

1. Ellis SG, Savage M, Fischman D, Baim DS, Leon M, Goldberg S, Hirschfeld JW, Cleman MW, Ternstein PS, Walker C, Bailey S, Buchbinder M, Topol EJ, Schatz RA: Restenosis after placement of Palmaz-Schatz stents in native coronary arteries: Initial results of a multicenter experience. Circulation 86:1836-1844, 1992.
2. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J: Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 85:916-927, 1992.
3. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, et al: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. NEJM 331:489-495, 1994.
4. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. NEJM 331:496-501, 1994.
5. Berquist D: Dextran and haemostasis. Acta Chir Scand 148:633-640, 1982.
6. Evarts CM: Low molecular weight dextran. Clin N Am 51:1285-1295, 1967.
7. Ljungstrom K-G, et al: Adverse reactions to dextran in Sweden. 1970-79. Acta Chir Scan 149:253-262, 1983.
8. Gelin LE, Solvell L, Zederfeldt B: Plasma volume expanding effect of low viscosity dextran and macrodex. Acta Chir Scand 122:309-323, 1961.
9. Merrill EW: Rheology of blood and flow in microcirculation. J Appl Physiol 18:255-260, 1963.
10. Wells RE, Merrill EW: Influence of flow properties of blood upon viscosity-hematocrit relationships. J Clin Invest 41:1591-1598, 1962.
11. Litwin MS: Blood viscosity in shock. Am J Surg 110:313-316, 1965.
12. Matheson NA: Letters to the editor: Low-molecular dextran. Lancet 1:1274-1275, 1964.
13. Bergentz SE, Gelin LE, Rudenstam CM: Fat thrombosis and anticoagulants: An experimental study. Nord Med 65:479-481, 1961.
14. Bernstein EF: Methods of measurement of red blood aggregation. Conference on evaluation of low molecular weight dextran in shock. Pharmacology and Pertinent Rheology, Nov. 1962, Washington, D.C., Division of Medical Sciences, National Academy of Sciences-National Research Council, 1963, pp 53-68, 69-71.
15. Bernstein EF, Evans RL: Protective action of low molecular weight dextran upon intravenous Hypaque toxicity. Surg Forum 11:141-142, 1960.
16. Bloom WL, Harmer DS, Bryant MF, Brewer SS: Coating of vascular surfaces and cells: A new concept in prevention of intravascular thrombosis. Proc Soc Exp Biol Med 115:384-386, 1964.
17. Swanson KT: Dogs, dextran and dilatation: A story of empiricism run wild. Cathet Cardiovasc Diagn 32:203-205, 1994.
18. Cox JL, Gotlieb AI: Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty. Can J Cardiol 4:201-210, 1988.
19. Bennett PN, Dhall DP, McKenzie FN, Matheson NA: Effects of dextran infusion on the adhesiveness of human blood-platelets. Lancet 2:1001-1003, 1966.
20. Aberg M, Bergentz SE, Hedner U: The effect of dextran on the lysability of ex vivo thrombi. Ann Surg 181:342, 1975.
21. Paull J: A prospective study of dextran-induced anaphylactoid reactions in 5745 patients. Anaesth Intensive Care 15:163-167, 1987.
22. Hedin H, et al: Incidence, pathomechanism and prevention of dextran-induced anaphylactic/anaphylactoid reactions in man. Dev Biol Stand 48:179-189, 1980.
23. Hattevig G, et al: Dextran reactive antibodies in children. Acta Paediatr Scand 72:849-851, 1983.
24. Hedin H, Richter W: Pathomechanisms of dextran-induced anaphylactoid/anaphylactic reactions in man. Int Arch Allergy Appl Immunol 52:145-159, 1976.
25. Bernstein RL, et al: A severe reaction to dextran despite hapten inhibition. Anesthesiology 67:567-569, 1987.
26. Cooper JAD, White DA, Matthay RA: Drug induced pulmonary disease. Am Rev Respir Dis 133:321-340 (Part I), 133:488-505 (Part II), 1986.
27. Cooper JAD, White DA, Matthay RA: Drug induced pulmonary disease. Am Rev Respir Dis 133:321-340 (Part I), 133:488-505 (Part II), 1986.
28. Taylor M, et al: Adult respiratory distress syndrome complicating intravenous infusion of low-molecular weight dextran. Cathet Cardiovasc Diagn 32:249-253, 1994.
29. Sumner WR, Michael JR, Wise RA: Acute Respiratory Failure. In Harvey AM, et al. (eds): "Principles and Practice of Medicine," 21st ed. Norwalk, CT: Appleton-Century-Crofts, 1984, pp 403-412.
30. Choban MJ, Kalhan SB, Anderson RJ, Collins R: Pulmonary edema and coagulopathy following intrauterine instillation of 32% dextran-70. J Clin Anesthesiol 3:317-319, 1991.
31. Zbella EA, Moise J, Carson SA: Noncardiogenic pulmonary edema secondarily to intrauterine instillation of 32% dextran-70. Fertil Steril 43:479-480, 1985.
32. Renck H, Ljungstrom K-G, Hedin H, Richter W: Prevention of dextran-induced anaphylactic reactions by hapten inhibition; III. Acta Chir Scand 149:355-360, 1983.
33. Berg EM, Fasting S, Sellevold OFM: Serious complications with dextran-70 despite hapten prophylaxis. Anesthesia 46:1033-1035, 1991.
34. Richter W: Hapten inhibition of passive antidextran anaphylaxis in guinea pigs. Int Arch Allergy 41:826, 1971.
35. Pasternak RC, Baughman KL, Fallon JT, Block PC: Scanning electron microscopy following coronary transluminal angioplasty with balloon dilation catheter. Circulation 5758 (Suppl II):II-242, 1978.
36. O'Gara PT, Guerrero JL, Feldman B, Fallon JT, Block PC: Effect of dextran and aspirin on platelet adherence after transluminal angioplasty of normal canine arteries. Am J Cardiol 53:1695-1698, 1984.
37. Swanson KT, Vlietstra RE, Holmes DR Jr, Smith HC, Reeder GS, Bresnahan JF, Bove AA: Efficacy of adjunctive dextran therapy during percutaneous angioplasty. Am J Cardiol 54:447-448, 1984.
38. Bowles MH: Efficacy of dextran therapy in coronary angioplasty. J Ark Med Soc 88:175-176, 1991.
39. Columbo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM: Intracoronary stenting without anticoagulation accomplished intravascular ultrasound guidance. Circulation 91:1676-1688, 1995.